← Back to Clinical Trials
Recruiting NCT06406283

NCT06406283 Active Young, Healthy Mind. The YoungFitT Project

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06406283
Status Recruiting
Phase
Sponsor University of Barcelona
Condition University Students
Study Type INTERVENTIONAL
Enrollment 219 participants
Start Date 2023-12-20
Primary Completion 2026-05-18

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
High-Intensity Functional Training (HIFT)Mindfulness-Based Stress Reduction Program (MBSR)Qigong

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 219 participants in total. It began in 2023-12-20 with a primary completion date of 2026-05-18.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The main objective of YoungFitT Project is to study the effect and neuro-psycho-biological mechanisms of mind and body interventions, also in the form of virtual reality (VR), on brain health, cognitive and psychological well-being of college students. The investigators have adopted an inter and multidisciplinary and multimodal approach to provide a more integrative perspective using cognitive, psychological, biochemical, and neuroimaging measurements. The investigators hypothesize that all three interventions Mindfulness-Based Stress Reduction (MBSR), Qigong, and High-Intensity Functional Training (HIFT) will produce gains in cognitive functions and psychological well-being at three months compared to baseline. Also, all three interventions will induce changes in the microbiota and brain structure and function. Finally, using a VR environment for these interventions will provide greater adherence and cognitive and psychological well-being benefits than conventional training.

Eligibility Criteria

Inclusion Criteria: * Individuals aged 18-25 years old * Fluency in Catalan or Spanish (I.e., able to understand and speak) * Accept to take part in the study and sign the informed consent according to the Declaration of Helsinki. Exclusion Criteria: * Severe Neurological or psychiatric history * Alcohol or drug abuse history * Injury that prevents exercise Exclusion criteria only for MRI examination: * Claustrophobia * Medical device (e.g., pacemaker implants, stents) * Other metal objects in the body Exclusion criteria only for VR study: * Dizziness * Contraindications or troubles that could condition the use of VR

Contact & Investigator

Central Contact

Maria Mataró, PhD

✉ mmataro@ub.edu

📞 +34933125052

Principal Investigator

Maria Mataró, PhD

PRINCIPAL INVESTIGATOR

University of Barcelona

Frequently Asked Questions

Who can join the NCT06406283 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying University Students. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06406283 currently recruiting?

Yes, NCT06406283 is actively recruiting participants. Contact the research team at mmataro@ub.edu for enrollment information.

Where is the NCT06406283 trial being conducted?

This trial is being conducted at Barcelona, Spain.

Who is sponsoring the NCT06406283 clinical trial?

NCT06406283 is sponsored by University of Barcelona. The principal investigator is Maria Mataró, PhD at University of Barcelona. The trial plans to enroll 219 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology